Amyotrophic lateral sclerosis gene therapy (Amarna Therapeutics/Treeway)

N/A

Report date: 2024/10/25 11:50:09

Base Information

Drug NameAmyotrophic lateral sclerosis gene therapy (Amarna Therapeutics/Treeway)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTreeway BVAmarna Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesAmarna Therapeutics BVTreeway BV
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A